CMD Bioscience

About:

CMD Bioscience develops molecular software applications for pharmaceutical, biotech and life sciences companies.

Website: https://www.cmdbioscience.com

Top Investors: LaunchCapital

Description:

CMD Bioscience LLC, a computational biotechnology company, develops a suite of molecular software applications for pharmaceutical, biotech, and life science companies. The company specializes in the peptide drug discovery and research projects. It offers CMDInventusSM, a computational platform for the computer-aided analysis protein-protein interactions (PPIs); analyzing, modeling, and optimizing protein and peptide structures; predicting the water-membrane partitioning behavior of peptides and proteins; and creating peptide therapeutics. The company also develops custom computational peptide discovery solutions, which include computer-enabled macromolecular target modeling and analysis, peptide-based hit identification, and peptide-based hit-to-lead optimization. CMD Bioscience LLC was founded in 2006 and is based in New Haven, Connecticut.

Total Funding Amount:

$925000

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New Haven, Connecticut, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)cmdbioscience.com

Founders:

Joseph Audie

Number of Employees:

1-10

Last Funding Date:

2012-12-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai